LI-CHUN CHANGCHIA-TUNG SHUNBEEN-REN LINSanduleanu, SilviaSilviaSanduleanuWEN-FENG HSUMING-SHIANG WUHAN-MO CHIU2022-01-142022-01-142021-091083-71591549-490Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/592387With the implementation of screening programs worldwide, diagnosis of early-stage colorectal cancer steadily increased, including T1 cancer. Current T1 cancer treatment does not differ according to anatomic location. We therefore compared the disease-free survival of T1 cancer arising from the rectum versus the colon.enAnatomic location; Colorectal cancer; Disease-free survival; T1 cancer[SDGs]SDG3carcinoembryonic antigen; adjuvant chemotherapy; adjuvant radiotherapy; advanced cancer; Article; cancer adjuvant therapy; cancer recurrence; cancer risk; cancer size; cancer staging; cancer surgery; cancer survival; cancer therapy; chromoendoscopy; cohort analysis; colon cancer; colonoscopy; colorectal cancer; disease free survival; endoscopic mucosal resection; endoscopic submucosal dissection; endoscopic surgery; endoscopy; esophagogastroduodenoscopy; female; follow up; histology; histopathology; human; human tissue; intestine preparation; length of stay; lymph node dissection; major clinical study; male; metastasis; narrow band imaging; neck dissection; neutrophil lymphocyte ratio; outcome assessment; overall survival; polypectomy; prevalence; rectum cancer; recurrence risk; retrospective study; risk assessment; risk factor; smoking; tonsillectomy; tumor invasion; tumor recurrence; aged; colon tumor; lymph node metastasis; middle aged; pathology; rectum; rectum tumor; Aged; Colonic Neoplasms; Female; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Rectal Neoplasms; Rectum; Retrospective StudiesRecurrence Outcomes Less Favorable in T1 Rectal Cancer than in T1 Colon Cancerjournal article10.1002/onco.13815339551212-s2.0-85106440074WOS:000654356100001https://scholars.lib.ntu.edu.tw/handle/123456789/571024